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ABSTRACT
The advent and subsequent widespread availability of preventive vaccines has altered the course of
public health over the past century. Despite this success, effective vaccines to prevent many high-
burden diseases, including HIV, have been slow to develop. Vaccine development can be aided
by the identification of immune response markers that serve as effective surrogates for clinically
significant infection or disease endpoints. However, measuring immune response is often costly,
which has motivated the usage of two-phase sampling for immune response sampling in clinical
trials of preventive vaccines. In such trials, measurement of immunological markers is performed
on a subset of trial participants, where enrollment in this second phase is potentially contingent
on the observed study outcome and other participant-level information. We propose nonparametric
methodology for efficiently estimating a counterfactual parameter that quantifies the impact of a
given immune response marker on the subsequent probability of infection. Along the way, we fill in
a theoretical gap pertaining to the asymptotic behavior of nonparametric efficient estimators in the
context of two-phase sampling, including a multiple robustness property enjoyed by our estimators.
Techniques for constructing confidence intervals and hypothesis tests are presented, and an open
source software implementation of the methodology, the txshift R package, is introduced. We
illustrate the proposed techniques using data from a recent preventive HIV vaccine efficacy trial.
1 Introduction
Ascertaining the population-level causal effects of exposures is often a motivating goal in scientific research. Such
effects are commonly formulated via summaries of the distribution of counterfactual random variables, which describe
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the values a measurement would have taken if, possibly counter-to-fact, a particular level of exposure were assigned
to the unit. Often, the exposure of interest is continuous-valued — for example, the dose of a drug, amount of weekly
exercise, or level of an immune response marker induced by a vaccine. The latter serves as our motivating example
as we consider data generated by a phase IIb trial of a vaccine to prevent infection by human immunodeficiency virus
(HIV), the HIV Vaccine Trials Network’s (HVTN) 505 efficacy trial (Hammer et al., 2013). In addition to evaluating
the overall efficacy of the vaccine, a key secondary question of the trial was to evaluate the role of vaccine-induced
immune responses in generating protective efficacy against HIV (Janes et al., 2017). Identification of immune response
markers causally related to protection is critical both for further developing a biological understanding of the action
mechanism of a vaccine’s effects and for insights to guide the development of future vaccines.
To study such relationships, it is natural to consider a dose-response curve that summarizes participants’ risk of HIV
infection as a function of the level of a particular immune response marker. A causal formulation of such a dose-
response analysis would consider a (possibly infinite) collection of counterfactual outcomes, each representing the HIV
infection risk that would have been observed if all individuals’ immune responses had been set to a particular level.
Studying how the proportion of infected individuals varies as a function of the level of an immune response marker
could provide insights into causal mechanisms underlying the vaccine’s effects. Unfortunately, several difficulties,
both theoretical and practical, arise when considering such a dose-response approach. From a statistical perspective,
nonparametric estimation and inference on the causal dose-response curve is challenging and requires non-standard
techniques (Dı´az and van der Laan, 2013; Kennedy et al., 2017; van der Laan et al., 2018). More importantly, such
an approach may require consideration of counterfactual variables that are scientifically unrealistic. Namely, it may
be impossible to imagine a world where every participant exhibits high immune responses, simply due to phenotypic
variability of participants’ immune systems. This calls into question the validity of counterfactual dose-response
analysis strategies that evaluate the effects of immune response markers.
An alternative framework for assessing the causal effects of continuous-valued exposures is rooted in considering
counterfactual outcomes resulting from stochastic interventions (Dı´az and van der Laan, 2012; Haneuse and Rotnitzky,
2013; VanderWeele and Hernan, 2013; Young et al., 2014). Whereas static interventions assign the same fixed level
of an exposure to all observed units, stochastic interventions consider instead setting the exposure level equal to a
random draw from a particular distribution. This approach provides a more flexible means of defining counterfactual
random variables. Indeed, static interventions can be viewed as a special case of stochastic interventions in which the
intervention mechanism is drawn from a degenerate distribution with all mass placed on only a single exposure level. In
order to define scientifically meaningful counterfactuals, care must be taken in defining the particular distribution from
which the exposure is drawn. A popular strategy is to draw exposure levels from a modified version of the true exposure
distribution — the natural distribution of the exposure that occurs under no intervention. For example, one may
consider an intervention that draws the post-vaccination level of immune response markers from a distribution that is
similar to the naturally observed (post-vaccination) distribution of immune response markers but that has been shifted
upwards (or downwards) for some or all participants. Counterfactuals defined by such an intervention may be better
aligned with plausible future interventions, such as refinements of the current vaccine that provide improved immune
response in some or all participants. Evaluating the population-level risk of HIV infection under such interventions
is scientifically useful for several reasons. Firstly, this measure of risk provides a scientifically relevant mechanism
by which to rank-order immune response markers by their importance for HIV infection risk. Such information could
be used in defining go/no-go criteria in future early-phase HIV vaccine development pipelines. Secondly, the risk
measure may also provide a way to predict next-generation vaccine efficacy based on the induced immune response
profile, elucidating whether the immune response induced by a candidate vaccine is sufficiently promising to advance
it to the clinical trials.
The above discussion highlights the need for rigorous methodology to identify and estimate population-level causal
effects of stochastic interventions; recent work has provided several candidate approaches (Dı´az and van der Laan,
2012; Haneuse and Rotnitzky, 2013; Young et al., 2014; Kennedy, 2019). Both Dı´az and van der Laan (2012) and
Haneuse and Rotnitzky (2013) propose conditions for the identification of the causal effect under a stochastic inter-
vention and detail several estimators of these quantities, including strategies relying on inverse probability weighting,
outcome regression, and doubly robust estimation. These approaches alone are insufficient for application to studies
like the HVTN 505 trial, where a two-phased, case-control sampling design was used to measure participants’ immune
response profiles. Under this design, all participants were HIV-negative at the week 24 visit, with eligible cases being
vaccine recipients diagnosed with HIV-1 infection by the month 24 visit; 100% of cases were sampled from among
those with samples available for measurement of immune response markers at the week 26 visit, while a random sam-
ple of eligible HIV-uninfected vaccine recipients was taken (Janes et al., 2017). This sampling design severely com-
plicates the estimation of causal effects. Rose and van der Laan (2011), among others, discuss strategies for efficient
estimation under two-phase sampling designs, emphasizing an inverse probability of censoring weighted modification
that may be coupled with targeted minimum loss estimation (or similar frameworks) to account for study design. Their
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approach yields an asymptotically linear estimator so long as the probability of inclusion in the second-phase sample
is known by design or estimable via nonparametric maximum likelihood. This latter requirement precludes usage
of their proposed estimators in situations where, for example, sampling probabilities depend on continuous-valued
covariates. While the term “two-phase sampling” has traditionally been used to denote outcome-dependent Bernoulli
or without-replacement sampling based on discrete covariates, recent efforts have extended the concept to the usage
of continuous-valued covariates in constructing second-phase samples (e.g., Chatterjee and Chen, 2007; Gilbert et al.,
2014). Consequently, Rose and van der Laan (2011) sketched a more complicated procedure for generating efficient
estimators in such settings. This approach has neither been evaluated via simulation nor in data analysis.
In the present work, we develop estimators of the mean counterfactual outcome under a stochastic intervention when
the exposure is measured via two-phase sampling. We provide several contributions to the disparate literatures on
two-phase sampling and stochastic interventions. To the former, we (i) formalize the assumptions needed for efficient
nonparametric inference under two-phase sampling; (ii) characterize a multiple robustness of the estimators that arises
from the second-order remainder of a linear expansion of the target parameter; and (iii) provide the first comparison
of the practical performance of these estimators in rigorous numerical experiments. Our contributions to the literature
on stochastic interventions are (i) a novel estimator of a conditional density that is valid under two-phase sampling,
while achieving a fast convergence rate, a crucial development for generating efficient estimators of the mean coun-
terfactual; and (ii) an extension of nonparametric inference on mean counterfactuals under stochastic interventions
using projections onto nonparametric working marginal structural models. Finally, we provide open source software
packages, txshift (Hejazi and Benkeser, 2020) and haldensify (Hejazi et al., 2020), for the R statistical program-
ming environment (R Core Team, 2020), that facilitate implementation of our proposed estimators and their nuisance
regression functions, respectively.
The remainder of this work is organized as follows. In Section 2, we introduce the target parameter (2.1) and discuss
prior work on stochastic interventions (2.2) and two-phase sampling (2.3). Section 3 includes discussion of strate-
gies for estimating nuisance regression functions (3.1) and the formulation of two estimators (3.2) that achieve the
nonparametric efficiency bound for estimation of the counterfactual mean under a stochastic intervention. Numerical
experiments comparing the proposed estimators to simpler variants are presented in section 4. Section 5 describes an
analysis of data from the HVTN 505 trial using our proposed methodology. We conclude by summarizing the results
of our statistical and scientific investigations and discussing avenues for future investigation.
2 Preliminaries and Background
2.1 Notation, data, and target parameter
Consider data generated by typical cohort sampling: the data on a single observational unit is denotedX = (W,A, Y ),
where W ∈ W is a vector of baseline covariates, A ∈ A a real-valued exposure, and Y ∈ Y an outcome of interest.
Initially, we assume access to n independent copies of X , using PX0 to denote the distribution of X . We assume a
nonparametric statistical model MX for PX0 . We denote by q0,Y the conditional density of Y given {A,W} with
respect to some dominating measure, q0,A the conditional density of A given W with respect to dominating measure
µ, and q0,W the density of W with respect to dominating measure ν. We use pX0 to denote the density of X with
respect to the product measure. This density evaluated on a typical observation x may be expressed
pX0 (x) = q0,Y (y | A = a,W = w)q0,A(a |W = w)q0,W (w) .
To define a counterfactual quantity of interest, we introduce a nonparametric structural equation model (NPSEM)
to describe the data-generating process of X (Pearl, 2000). Specifically, we assume the data are generated by the
following system of structural equations:
W = fW (UW );A = fA(W,UA);Y = fY (A,W,UY ),
where {fW , fA, fY } are deterministic functions, and {UW , UA, UY } are exogenous random variables.
The NPSEM provides a parameterization of pX0 in terms of the distribution of the random variables (X,U) modeled
by the system of structural equations. Importantly, it also implies a model for the distribution of counterfactual
random variables generated by specific interventions on the data-generating process. For example, a static intervention
replaces fA with a value a in the support of A. By contrast, a stochastic intervention modifies the value A would
naturally assume, fA(W,UA), replacing it with a draw from a post-intervention distribution q˜0,A(· | W ), where the
zero subscript is included to emphasize that this distribution may depend on PX0 . A static intervention may be viewed
as a particular type of stochastic intervention in which q˜0,A(· | W ) places all mass on a single point. Dı´az and
van der Laan (2012) described a stochastic intervention that draws A from a distribution such that q˜0,A(a | W ) =
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q0,A(a − δ(W ) | W ) for a user-supplied shifting function δ(W ) and a given a ∈ A. Haneuse and Rotnitzky (2013)
showed that estimating the effect of this intervention is equivalent with that of an intervention that modifies the value
A would naturally assume according to a regime d(A,W ). Importantly, the regime d(A,W ) may depend on both
the covariates W and the exposure level A that would be assigned in the absence of the regime; consequently, this
has been termed a modified treatment policy (MTP). Both Haneuse and Rotnitzky (2013) and Dı´az and van der Laan
(2018) considered an MTP of the form d(a,w) = a + δ(w) for δ(w) = γ ∈ R if a + γ ≤ u(w) and d(a,w) = a
if a + γ > u(w), where u(w) is the maximum value in the support of q0,A(· | W = w). This intervention generates
a counterfactual random variable YA+δ(W ) := fY (A + δ(W ),W,UY ) whose distribution we denote P δ0 ; we seek to
estimate ψ0,δ := EP δ0 {YA+δ(W )}, the mean of this counterfactual outcome.
In the context of the HVTN 505 trial, this parameter corresponds to the counterfactual risk of HIV-1 infection had the
levels of immune response markers of vaccinated participants been increased by γ units relative to the level induced
by the current vaccine. This quantity may reflect the immune response marker distribution of a next-generation HIV
vaccine with improved immunogenicity relative to the vaccine evaluated in HVTN 505. While the magnitude of
shifting could generally be allowed to vary with participant characteristics, in our analysis, we consider an intervention
that uniformly shifts all participants’ immune responses by γ units, that is, d(a,w) = a + γ for all a ∈ A. Note that
for HVTN 505, the parameter of interest is defined only for the vaccine group, making A a post-vaccination marker
measuring an HIV-specific immune response. Importantly, it is not conceivable to define the target parameter for
placebo recipients since only HIV-negative participants are enrolled in the trial and A is only defined if measured
prior to HIV infection; consequently, all relevant placebo recipients have value zero for the marker A, and it is not
meaningful to apply d(a,w) to shift the distribution of A.
Analysis of the HVTN 505 trial is complicated by its two-phase sampling design, a technique commonly used for
assessing vaccine-mediated immune response in efficacy trials (Haynes et al., 2012). In general two-phase sampling,
we do not observe X on all participants. Instead, we observe O = (W,C,CA, Y ) ∼ P0, where P0 is the distribution
of O and C is an indicator that an observation is included in the second-phase sample. In particular, Ci = 1 if A
is measured on the ith observation and Ci = 0 otherwise. By convention, CA denotes that unobserved values of A
are set to zero; this arbitrary labeling has no effect on our subsequent developments. In the context of vaccine trials,
the probability of inclusion in the second-phase sample often depends on W and Y ; for each w and y we define
g0,C(y, w) := P(C = 1 | Y = y,W = w). Consequently, P0 ∈ M = {PPX0 ,g0,C : PX0 ∈ MX , g0,C}— that is,
P0 is the distribution of O implied by the pair {PX0 , g0,C}. For example, in HVTN 505 all infected participants with
samples available for marker measurement at week 28 had immune responses measured, i.e., g0,C(1, w) = 1 for all
w; however, only a subset of non-infected participants had immune responses measured. We will assume access to
an i.i.d. sample O1, . . . , On, denoting its empirical distribution by Pn. The statistical estimation problem is thus to
develop efficient nonparametric estimators of ψ0,δ based on n independent realizations of the observed data unit O.
2.2 Identifying the counterfactual mean under a stochastic intervention
Dı´az and van der Laan (2012) established that ψ0,δ is identified by
ψ0,δ =
∫
W
∫
A
Q0,Y (a,w)q0,A(a− δ(W ) |W = w)q0,W (w)dµ(a)dν(w)
=
∫
W
∫
A
Q0,Y (a+ δ(w), w)q0,A(a |W = w)q0,W (w)dµ(a)dν(w) (1)
where Q0,Y (a,w) := EPX0 [Y | A = a,W = w], the conditional mean of Y given A = a and W = w, as implied
by PX0 . For the statistical functional given in equation (1) to correspond to the causal estimand of interest, several
untestable assumptions are required, including
• Consistency: Y ai+δ(wi)i = Yi in the event Ai = ai + δ(wi), for i = 1, . . . , n;
• Lack of interference (stable unit treatment value): Y ai+δ(wi)i does not depend on aj + δ(wj) for i 6= j and
i = 1, . . . , n (Rubin, 1978, 1980);
• No unmeasured confounding (strong ignorability): Ai ⊥ Y ai+δ(wi)i |W = wi, for i = 1, . . . , n; and
• Positivity (overlap): ai ∈ A =⇒ ai + δ(wi) ∈ A |W = wi for all w ∈ W and i = 1, . . . n.
The positivity assumption required to establish equation (1) is unlike that required for static or dynamic interventions.
In particular, it does not require that the post-intervention exposure density place mass across all strata defined by
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W . Instead, for Q0,Y to be well-defined, we require that the post-intervention exposure mechanism be bounded, i.e.,
PPX0 {q0,A(A− δ(W ) |W )/q0,A(A |W ) > 0} = 1, which is satisfied by our choice of δ(W ).
Dı´az and van der Laan (2012) further provided the efficient influence function (EIF) of ψ0,δ with respect to a nonpara-
metric model, using this object as a key ingredient in the construction of their proposed estimators. The EIF, evaluated
on a typical full data observation x, is
DF (PX0 )(x) = H(a,w){y −Q0,Y (a,w)}+Q0,Y (a+ δ(w), w)− ψ0,δ, (2)
where
H(a,w) = 1(a < u(w))
q0,A(a− δ(w) | w)
q0,A(a | w) + 1(a+ δ(w) ≥ u(w)). (3)
2.3 Correcting for two-phase sampling
Since the earliest discussion of two-phase sampling (Neyman, 1938), a rich literature on such designs has
emerged (e.g., Manski and Lerman, 1977; White, 1982; Flanders and Greenland, 1991; Chatterjee et al., 2003; Breslow
et al., 2009a,b; Dai et al., 2009; Gilbert et al., 2014). Early proposals of estimation strategies focused on parametric
models of the sampling mechanism (Breslow and Cain, 1988), while Robins et al. (1994, 1995) introduced the first
semiparametric estimator to incorporate inverse probability of sampling weights. Lawless et al. (1999) proposed a
discretization-based procedure that uses stratum membership (across a small number of discrete strata) to construct
the second-phase sample. Breslow and Holubkov (1997) proposed the use of maximum likelihood estimation (MLE)
when a logistic regression may be used to link the outcome to all covariates, while Breslow et al. (2003) established
the nonparametric MLE and its asymptotic properties for this class of problem. Subsequent proposals include pseu-
doscore estimators (Chatterjee et al., 2003), which may accommodate the use of continuous covariates in the sampling
mechanism via kernel smoothing but require discrete covariates in the second-phase sample (Chatterjee and Chen,
2007); re-calibration under semiparametric regression (Chen and Chen, 2000; Fong and Gilbert, 2015); and targeted
minimum loss estimation (Rose and van der Laan, 2011).
We build on the results of Rose and van der Laan (2011), who provide a study of nonparametric efficiency theory in
two-phase sampling designs. In particular, they provide a representation of the EIF of a target parameter of the full
data distribution PX0 when the observed dataO1, . . . , On are generated by a two-phase sampling design. Their general
developments suggest that, in the present problem, the EIF evaluated on a typical observation from the observed data
o = (w, c, ca, y), is
D(G0, g0,C , D
F (PX0 ))(o) =
c
g0,C(y, w)
DF (PX0 )(o)−
(
c
g0,C(y, w)
− 1
)
G0(y, w) , (4)
where DF (PX0 ) is the EIF in (2), and G0(y, w) := EP0 [DF (PX0 )(O) | C = 1, Y = y,W = w] is the conditional
mean of DF (PX0 ) given Y = y and W = w in the second-phase sample.
Rose and van der Laan (2011) proposed two estimation strategies. The first — which we call the reweighted esti-
mator — incorporates inverse probability weights based on known or estimated values of the second-phase sampling
probability g0,C to an EIF-based estimation procedure such as one-step estimation or targeted minimum loss (TML)
estimation. The estimator is shown to be asymptotically linear and efficient in designs where the sampling mechanism
is known or can be estimated using nonparametric maximum likelihood. The second estimator described in this pro-
posal is for situations where the sampling design is unknown and must be estimated using nonparametric regression,
such as when the censoring process is outside the control of investigators; however, the authors did not provide a
formal study of the theoretical properties of this estimator nor any numerical evaluations. Owing to its complexity,
examples of this approach are extremely limited (e.g., Brown, 2014). We aim to fill in these gaps by providing formal
theory establishing conditions under which this estimator achieves asymptotic efficiency as well as numerical studies
demonstrating its performance in the context of estimating the counterfactual mean of a stochastic intervention.
3 Methodology
We now describe the implementation of our proposed estimators. We utilize two frameworks for estimation: the
one-step framework (Pfanzagl and Wefelmeyer, 1985; Bickel et al., 1993) and TML estimation (van der Laan and
Rubin, 2006; van der Laan and Rose, 2011, 2018). Both estimators develop in two stages, with crucial differences
appearing in the second stage. In the first stage, we construct initial estimators of key nuisance quantities, while in
the second stage we perform a bias-correction based on the estimated EIF. The one-step framework updates an initial
substitution estimator by adding the empirical mean of the estimated EIF. By contrast, the TML estimation framework
5
APRIL 7, 2020
uses a univariate logistic tilting model to build a targeted estimator of Q0,Y , which is subsequently used to construct
an updated substitution estimator.
3.1 Estimating nuisance parameters
Our general strategy for estimating nuisance parameters relies on first using the entire observed data set to estimate
the second-phase sampling probabilities, g0,C . Subsequently, inverse probability of sampling weights based on these
estimates are used to generate estimates of relevant full data quantities using data available only on observations in
the second-phase sample. These quantities include the outcome regression Q0,Y , the exposure density q0,A, and the
joint distribution of covariates and exposure, which we denote by Q0,AW . Finally, estimates of full data quantities are
used to estimate G0, the conditional mean of the full data EIF given Y and W amongst observations included in the
second-phase sample.
Excepting Q0,AW , which we estimate using an inverse probability of sampling weighted empirical distribution, we
describe both parametric and flexible, data adaptive estimators. The data adaptive estimators are more parsimonious
with our theoretical developments, which pertain to nonparametric-efficient estimation; nevertheless, our develop-
ments hold equally well for parametric working models. In theorem 1, we detail assumptions on the stochastic be-
havior of estimators of these nuisance functions and relate these to the behavior of the resultant estimator of the target
parameter.
An estimator of the sampling mechanism g0,C could be derived from any classification method (e.g., logistic regres-
sion), in which PP0(C = 1 | Y,W ) is estimated using the full sample; however, nonparametric or semiparametric
estimation may be preferable depending on the availability of information about the two-phase sampling design.
To generate an estimate Qn,AW of the full data joint distribution of (A,W ), we use a stabilized inverse probability
weighted empirical distribution. For a given (a,w),
Qn,AW (a,w) :=
∑n
i=1
Ci
gn,C(Yi,Wi)
1(Ai ≤ a,Wi ≤ w)∑n
i=1
Ci
gn,C(Yi,Wi)
.
To estimate Q0,Y , one may again use any classification or regression model, where Y is the outcome and functions of
A and W are included as predictors. In fitting this model, inverse probability of sampling weights Ci/gn,C(Yi,Wi)
for i = 1, . . . , n, are included to account for the two-phase sampling design. Any valid regression estimator may
be leveraged for this purpose, so long as the implementation of the estimator respects the inclusion of sample-level
weights; in practice, we recommend the use of a semiparametric or nonparametric estimator. We denote byQn,Y (a,w)
the estimate evaluated on a data unit with A = a,W = w.
The simplest strategy for estimating the generalized propensity score q0,A is to assume a parametric working model
and use standard regression techniques to generate suitable estimates of the density. For example, one could operate
under the working assumption that A given W follows a Gaussian distribution with homoscedastic variance and mean∑p
j=1 βjφj(W ), where φ = (φj : j) are user-selected basis functions and β = (βj : j) are unknown regression
parameters. In this case, a density estimate would be generated by fitting a linear regression of A on φ(W ) (e.g.,
minimizing inverse probability of sampling weighted least squares) to estimate the conditional mean of A given W ,
paired with an estimate of the variance of A. In this case, the estimated conditional density is given by the density of
a Gaussian distribution evaluated at these estimates.
The relative dearth of available estimators of a conditional density motivated our development of a novel estimator
that accounts for two-phase sampling designs. We detail this approach in the Supplementary Materials and provide
an implementation of our proposal in the haldensify R package (Hejazi et al., 2020). Going forward, we denote by
qn,A(a | w) the estimated conditional density of A given W = w, evaluated at a ∈ A.
The final nuisance parameter that must be estimated is G0, the conditional mean of the random variable DF (PX0 )(O)
given (Y,W ) amongst those included in the second-phase sample. To estimate this quantity, we generate a pseudo-
outcome as follows. First, define the substitution estimator,
ψn,δ :=
∫
Qn,Y (a+ δ(w), w)dQn,AW (a,w) =
∑n
i=1
Ci
gn,C(Yi,Wi)
Qn,Y (Ai + δ(Wi),Wi)∑n
i=1
Ci
gn,C(Yi,Wi)
, (5)
as well as the auxiliary term
Hn(a,w) := 1(a < u(w))
qn,A(a− δ(w) | w)
qn,A(a | w) + 1(a+ δ(w) ≥ u(w)) .
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Using these quantities, for all i such that Ci = 1, we compute
DFn,i := Hn(Ai,Wi){Yi −Qn,Y (Ai,Wi)}+Qn,Y (Ai + δ(Wi),Wi)− ψn,δ .
A simple estimation strategy for G0 is to adopt a parametric working model and fit, for example, a linear regression
of the pseudo-outcome DFn,i on basis functions of Y and W . Importantly, since G0 is defined as a conditional ex-
pectation with respect to the observed data distribution, we need not include inverse probability of sampling weights
in this regression estimate. While a parametric working model for G0 is permissible, given the complexity of the
object, correct specification of this model is likely challenging and we recommend more flexible approaches. We let
Gn(Yi,Wi) denote the value of the chosen regression estimator evaluated on the ith observation i = 1, . . . , n.
3.2 Efficient estimation
3.2.1 One-step estimator
Based on the estimated nuisance functions detailed above, efficient estimators may be constructed using either of the
one-step or targeted minimum loss estimation frameworks. The one-step estimator adds the empirical mean of the
estimated EIF to the initial plug-in estimator,
ψ+n,δ := ψn,δ +
1
n
n∑
i=1
[
Ci
gn,C(Yi,Wi)
DFn,i −
{
Ci
gn,C(Yi,Wi)
− 1
}
Gn(Yi,Wi)
]
. (6)
The resultant augmented one-step estimator ψ+n,δ relies on the nuisance functions estimators (Qn,Y , gn,A, Gn, gn,C).
Theorem 1 details sufficient assumptions on these estimators for ensuring that the one-step is asymptotically efficient.
3.2.2 Targeted minimum loss estimator
An asymptotically linear TML estimator of ψ0,δ may be constructed by using inverse probability of sampling weights
to update the initial estimator Qn,Y to an estimator Q
?
n,Y . An updated plug-in estimator is then constructed,
ψ?n,δ :=
∫
Q
?
n,Y (a+ δ(w), w)dQn,AW (a,w) . (7)
This updated estimator Q
?
n,Y is constructed as follows.
1. Define a working logistic regression model for the conditional mean of C given {Y,W}, logit(gn,C,ξ) =
logit(gn,C) + ξ(Gn/gn,C) : ξ ∈ R. The MLE ξn of the parameter ξ of this model is computed and the updated
estimator g?n,C := gn,C,ξn is defined.
2. Next, define a working logistic regression model for the conditional mean of Y given {A,W}: logit(Qn,Y,) =
logit(Qn,Y ) + Hn :  ∈ R. An estimate n of  is obtained using weighted logistic regression with weights
Ci/g
?
n,C(Yi,Wi) and Q
?
n,Y := Qn,Y,n .
The outlined procedure includes two targeting steps. The first of these steps constructs an update of the initial estimator
of the second-phase sampling probability, g?n,C , based on the initial estimate of Gn. This step ensures that the revised
estimate satisfies
∑n
i=1{Gn(Yi,Wi)/g?n,C(Yi,Wi}{Ci − g?n,C(Yi,Wi)} = 0 in a single step when a universal least
favorable submodel (van der Laan and Gruber, 2016) is used, though an iterative procedure may be used to achieve the
same result. In the second step, the updated outcome regression Q
?
n,Y is generated based on the conditional density
estimate qn,A; the inclusion of weights in the regression ensures that
∑n
i=1 Ci/gn,C(Yi,Wi)D
F
n,i = 0.
When the first step of this procedure is omitted, the resultant TML estimator is equivalent to the reweighted estimator
of Rose and van der Laan (2011). The additional step allows our estimator to attain asymptotic linearity in a broader
setting. That is, while the reweighted estimator requires that the sampling weights be known or be estimable at a
parametric rate, our approach allows for the use of more flexible estimators of sampling weights.
3.2.3 Asymptotic analysis of efficient estimators
We establish the asymptotic efficiency of our estimators in theorem 1. The theorem depends on a several regularity
conditions, which are discussed in the Supplementary Materials. The theorem is provided in the context of the TML
estimator, but, with a similar set of assumptions, the same result holds for the one-step estimator; for brevity, we omit
this analogous theorem. In the sequel, DF (Q0,Y , q0,A) and D
F (PX0 ) are used interchangeably since D
F depends on
PX0 primarily through estimates of the nuisance functions Q0,Y and q0,A.
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Theorem 1 (Asymptotic linearity and efficiency of the TML estimator ψ?n,δ). Assuming conditions C1-C6,
n1/2
(
ψ?n,δ − ψ0,δ
)
= n−1/2
n∑
i=1
D(G0, g0,C , D
F (Q0,Y , g0,A))(Oi) + op(1) .
An immediate corollary of theorem 1 is that ψ?n,δ is asymptotically efficient, since it is an asymptotically linear es-
timator with influence function equal to the efficient influence function. Moreover, the central limit theorem implies
that the scaled, centered estimator converges in distribution to a mean-zero Gaussian random variable with variance
matching that of the EIF (i.e., EP0{D(G0, g0,C , DF (Q0,Y , g0,A))(O)2}).
The proof of theorem 1 is given in the Supplementary Materials. The conditions of the theorem are standard in
semiparametric inference problems, essentially requiring a sub-parametric rate of convergence of each of the nui-
sance estimators to their true counterparts, a Donsker class condition on the EIF evaluated at the estimated nuisance
parameters, and L2(P0)-consistency of this same object.
With respect to this first condition, we note that the highly adaptive lasso (HAL) regression estimator has been shown
to achieve a sufficiently fast rate of convergence so as to satisfy the requirements of the theorem (van der Laan, 2017;
Benkeser and van der Laan, 2016; Bibaut and van der Laan, 2019; Coyle et al., 2019) under the assumption that the
true regression function is right-hand continuous with left-hand limits and bounded sectional variation norm. This
provided further motivation for our development of a HAL-based conditional density estimator. We note that our
simulation studies and analysis of the HVTN 505 trial data utilize HAL to increase the applicability of our theorem.
With respect to the Donsker condition, we note that this assumption may be avoided by using cross-validation (or
cross-fitting) in estimating nuisance parameters (Klaassen, 1987; Zheng and van der Laan, 2011; Chernozhukov et al.,
2016). Such an estimator enjoys the same asymptotic properties as our non-sample-splitting estimator while eschewing
the Donsker class condition.
3.2.4 Multiple robustness of efficient estimators
The EIF of our estimators enjoys a multiple robustness property, which allows our estimators to achieve consistency
even in situations where certain combinations of nuisance parameters are inconsistently estimated.
Lemma 1 (Multiple robustness of the EIF). Let (G, gC , QY , qA) denote the limits of the nuisance estimators
(Gn, g
?
n,C , Q
?
n,Y , qn,A) in probability. Suppose either of the following two conditions hold
(i) G = G0 and either QY = Q0,Y or qA = q0,A;
(ii) gC = g0,C and either QY = Q0,Y or qA = q0,A.
Then ψ?n,δ −→p ψ0,δ .
In the case of the one-step estimator, the initial nuisance function estimates gn,C and Qn,Y are used instead. The
lemma implies that our efficient estimators will be asymptotically consistent if at least one of (G0, g0,C) and one of
(Q0,Y , q0,A) are consistently estimated.
3.3 Confidence intervals and hypothesis tests
Theorem 1 established the limiting distribution of our efficient estimators. From the limit distribution, inference for
either estimator may be attained in the form of Wald-type confidence intervals and corresponding hypothesis tests.
Consider the null and alternative hypotheses H0 : ψ0,δ = 0 and H1 : ψ0,δ 6= 0, and denote by ψn,δ either the TML
estimator ψ?n,δ or the one-step estimator ψ
+
n,δ . Asymptotic (1 − α) Wald-type confidence intervals and p-values for
the hypothesis test are given by
p-value = 2
[
1− Φ
(
n1/2 | ψn,δ |
σn
)]
and CI = ψn,δ ± z(1−α/2)σn/n1/2 ,
where σ2n is the empirical variance of the estimated EIF, Φ(·) is the CDF of the standard normal distribution, and
z(1−α/2) is the 1− α/2 quantile of the same distribution.
These procedures are asymptotically justified under the conditions of theorem 1. Importantly, while multiple robust-
ness implies that consistent estimation of ψ0,d is possible under inconsistent estimation of some nuisance parameters,
the validity of confidence intervals and hypothesis tests requires consistent estimation of all nuisance parameters.
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3.4 Summarization via working marginal structural models
Estimation of ψ0,δ for a single pre-specified shift δ may be unsatisfactory in some contexts, as it does not provide infor-
mation concerning a dose-response relationship between exposure and outcome. Thus, to develop an understanding of
a dose-response pattern in the context of stochastic interventions, it may be informative to estimate the counterfactual
mean outcome across several values of δ. In the context of HVTN 505, we consider estimation of a grid of coun-
terfactual means ψ0 = (ψn,δ1 , . . . , ψn,δK ) and examine how the risk of HIV infection varies with choice of δ over a
fixed grid, i.e., δk ∈ {δ1, . . . , δK}. After estimating the counterfactual mean for each δk, a summary measure relating
the stochastic interventions to the mean counterfactual outcomes may be constructed by projection onto a working
marginal structural model (MSM). For example, we might consider a (possibly weighted) least-squares projection on
the linear working model mβ(δ) = β0 + β1δ, in which case the parameter β1 corresponds to the linear trend in mean
counterfactual outcomes as a function of the δk.
More generally, we can define β(δ) = argminβ∈Rd
∑
δ∈{δ1,...,δK} h(δ){ψ0,δ −mβ(δ)}2, for a user-selected weight
function h(δ). We note that adjustment of the weight function, as well as the functional form of mβ(δ), allow for a
wide variety of working models to be considered. Alternatively, β(δ) can be viewed as the solution of
0 = U(β, ψ) =
∑
δ∈{δ1,...,δK}
h(δ)
d
dβ
mβ(δ){ψ0,δ −mβ(δ)}.
The goal is to make statistical inference on the parameter β. We note that this approach does not assume a linear
dose-response curve, but rather uses a working model to summarize the relationship between exposure and outcome
(Neugebauer and van der Laan, 2007). This approach is distinct from that of Haneuse and Rotnitzky (2013), whose
proposal involving MSMs pertains specifically to parametric models.
To estimate β, we assume access to the TML or one-step estimates ψn = (ψn,δ1 , . . . , ψn,δK ) for each δk. The estimate
βn of β is the solution in β of the equation 0 = U(β, ψn). To derive the limit distribution of βn, let D0,ψ denote a
vector whose kth entry is the EIF associated with parameter ψ0,δk . The delta method implies that the influence function
of βn is Dβ = [− ddβU(β, ψ0)−1] ddψ0U(β, ψ0)Dψ0 , and that n1/2(βn − β) converges in distribution to a mean-zero
Gaussian random variable with variance Σ = EP0{Dβ(O)2}. The empirical covariance matrix of D0,ψ evaluated at
nuisance parameter estimates serves to estimate Σ.
4 Simulation Studies
The proposed estimators were evaluated using two simulation experiments. In the first, we compare our proposed
estimators to alternative estimators proposed in the literature. To highlight the benefits offered by our approach over
the simple reweighted estimator of Rose and van der Laan (2011), we focus on how estimation of g0,C influences
the estimator performance. In particular, we consider both the usage of standard logistic regression and the highly
adaptive lasso in the construction of gn,C .
In a second simulation study, we analyze the performance of our estimators using a data-generating mechanism that
is inspired directly by data from the HVTN 505 trial. Here, we focus on comparing the relative performance of our
efficient, augmented one-step and TML estimators to assess their capabilities for use in real-world data analysis.
In both simulation studies, we consider estimation of ψ0,δ for several values of δ. These studies were performed using
the txshift R package (Hejazi and Benkeser, 2020), available at https://github.com/nhejazi/txshift.
4.1 Simulation #1: Comparing estimators under different sampling mechanism estimators
We evaluate the estimators on data simulated from the following data-generating mechanism:
W1 ∼ Normal(3, 1);W2 ∼ Bernoulli(0.6);W3 ∼ Bernoulli(0.3)
A |W ∼ Normal(2(W2 +W3), 1)
Y | A,W ∼ Bernoulli (expit ((W1 +W2 +W3)/3−A))
C | Y,W ∼ Bernoulli (expit ((W1 +W2 +W3)/3− Y )) ,
where expit(x) = {1+exp(−x)}−1. In this setting, the outcome has a fairly high event rate, with P(Y = 1 | A,W ) ≈
0.415. We used this data-generating process to sample n i.i.d. observations for n ∈ {100, 400, 900, 1600, 2500} and
used the resultant data to estimate the target parameter with each of the estimators considered. This was repeated 1000
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times. We considered estimation of ψ0,δ for δ ∈ {−0.5, 0, 0.5}, where the corresponding true values of the target
parameter were approximately {0.501, 0.415, 0.333}.
We compared the reweighted estimators of Rose and van der Laan (2011) to our proposed estimators. For reference, we
also present the results of a naive estimate that ignores the two-phase sampling design. In each of these three cases, we
consider one-step and TML estimators, giving six estimators in total. Each of these six estimators was constructed by
estimating the exposure mechanism qn,A and outcome mechanism Qn,Y via maximum likelihood based on correctly
specified parametric models, while gn,C was constructed using either logistic regression or the highly adaptive lasso.
Although a parametric regression model adequately captures the true functional form of the sampling mechanism in
this data-generating process, one may not have access to such information about the sampling mechanism in practice.
In this case, nonparametric regression is preferable. This motivated our desire to examine the relative performance of
the reweighted versus our proposed estimators under such a setting. Based on theory, when gn,C is estimated using
logistic regression, we would expect both the reweighted estimator and our proposed estimator to be asymptotically
linear, which would be supported by observing that the bias of the estimators disappears faster than n−1/2-rate. On the
other hand, when gn,C is nonparametrically estimated (in our simulation, via the highly adaptive lasso), the reweighted
estimators should not achieve asymptotic linearity, while our proposed estimators should. The naive estimators, which
make no adjustment for the two-phase sampling design, were expected to perform poorly — even though this is a
“best case” scenario for these estimators in the sense that the two nuisance parameters are correctly estimated using
parametric models.
We compared all estimators in terms of their bias (scaled by n1/2), mean squared-error (scaled by n), and coverage of
95% Wald-style confidence intervals. Figure 1 summarizes our findings for the case δ = 0.5, while Figures S1 and S2,
in the Supplementary Materials, present results for δ = 0 and δ = −0.5, respectively.
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Figure 1: Results of numerical simulations comparing six estimation strategies for ψ0,δ for δ = 0.5, across 1000
Monte Carlo simulations for each of five sample sizes. The naive estimators do not make use of the estimated sampling
mechanism gn,C , so their performance is displayed only in the upper panel, in the interest of visual economy.
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When the sampling mechanism is estimated via a correctly specified parametric model (upper panel), the reweighted
and our proposed estimators behave as expected, with low bias and stable MSE. However, the reweighted estimators
display coverage exceeding 95%, while our proposed estimators achieve nominal coverage. This occurs because the
influence function provided in Rose and van der Laan (2011), which is the basis for the standard error estimates used
to build these confidence intervals, does not include the first-order contribution due to estimation of the sampling
mechanism. The result is a conservative standard error estimate. Unsurprisingly, we found that the naive estimator
performed poorly in all sample sizes, highlighting the importance of appropriately accounting for sampling design.
When the sampling mechanism was estimated using HAL (lower panel), the reweighted estimators do not attain
asymptotic linearity, as evidenced by the scaled bias and MSE increasing with sample size. On the other hand our
proposed estimators have small bias and MSE approaching the efficiency bound, thus demonstrating the benefits of
the additional effort required to produce our estimators over the simpler reweighted estimators.
4.2 Simulation #2: Comparing estimators in a scenario based on the HVTN 505 trial
For use in real data analysis, we examine only our augmented one-step and TML estimators. We used the HVTN data
to calibrate the following data-generating mechanism:
W1 ∼ Normal(26.6, 5.7);W2 ∼ Poisson(40);W3 ∼ Bernoulli(0.4);W4 ∼ Bernoulli(0.3)
A |W ∼ Normal(−1.37 + 0.004W1 + 0.015W2 + 0.05W3 + 0.25W4, 0.22)
Y | A,W ∼ Bernoulli (expit(−2.9− 0.0013W1 − 0.0016W2 + 0.0678W3 + 0.039W4 − 0.033A))
C | Y,W ∼
{
Bernoulli (expit(−2.45− 0.027W1 + 0.012W2 + 0.39W3 + 0.166W4)) , Y = 0
1, Y = 1
.
For consistency with the observed rate of HIV infection in the HVTN 505 trial, the outcome was made to have a rela-
tively rare event rate, with P(Y = 1 | A,W ) ≈ 0.059. We considered a setting where we observed n = 1400 i.i.d. ob-
servations, approximately matching the sample size of the vaccinated arm in HVTN 505. Estimator performance was
assessed and reported by aggregating across 1000 repetitions. Under this data-generating mechanism, the true param-
eter values were approximated as ψ0,δ = {0.0627, 0.0617, 0.0609, 0.0598, 0.0589, 0.0580, 0.0571, 0.0561, 0.0554}
for δ ∈ {−2.0,−1.5,−1.0,−0.5, 0.0, 0.5, 1.0, 1.5, 2.0}, respectively. An analogous setting, in which the effect of
exposure on the outcome was removed, yielded similar results; these are presented in the Supplementary Materials.
The proposed estimators were constructed by using the highly adaptive lasso to estimate the sampling mechanism
gn,C , the exposure mechanism qn,A, the outcome mechanism Qn,Y , and the pseudo-outcome regression Gn. We
compared the proposed one-step and TML estimators in terms of their bias and MSE. The results are summarized in
Figure 2.
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Figure 2: Results of numerical simulations comparing our two proposed estimators of ψ0,δ for a grid of δ, across 1000
Monte Carlo simulations at n = 1400.
Inspection of the bias and MSE indicates that both of our proposed estimators display adequate performance, with
small finite-sample bias and mean-squared error. In terms of bias and MSE, the performance of the two estimators is
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nearly indistinguishable. From these numerical investigations, we concluded that our augmented estimators are both
well-suited to estimating ψ0,δ in the context of a re-analysis of data from the HVTN 505 trial.
5 Application to the HVTN 505 Trial
The HVTN 505 trial was a randomized control trial that enrolled 2504 HIV-negative participants and randomized
participants 1-to-1 to receive an active vaccine or placebo. The one-year incidence of HIV-1 infection was about
1.8% per person-year in the vaccine arm and 1.4% per person-year in the placebo arm, during primary follow-up
for HIV-1 acquisition (between week 28 and month 24; the same period as was used for assessment of immune
correlates). Blood was drawn post-vaccination and immune responses measured via intracellular cytokine staining
of preserved HIV-1-stimulated peripheral blood mononuclear cells for all HIV-1 cases diagnosed between week 28
and month 24 and a random sample of uninfected controls (Janes et al., 2017). The two-phase sampling of vaccine
recipient controls without-replacement sampled five controls per case within each of eight baseline covariate strata
defined by categories of body mass index and race/ethnicity (White, Hispanic, Black). Janes et al. (2017) provide the
first immune correlates analysis of the HVTN 505 data based on the constructed two-phase sample, focusing on two
cellular immune responses: the Envelope CD4+ and CD8+ polyfunctionality scores. Subsequently, Fong et al. (2018)
analyzed an expanded set of immune markers, including six primary humoral immune response variables beyond the
two first studied by Janes et al. (2017). Both sets of analyses found the CD4+ and CD8+ polyfunctionality scores to
be informative of HIV-1 infection status by month 24 of the study (end of follow-up).
We examined how a range of posited shifts in standardized polyfunctionality scores of the CD4+ and CD8+ im-
mune markers would impact the mean counterfactual risk of HIV-1 infection in vaccine recipients. We consid-
ered standardized polyfunctionality scores, so that our pre-specified grid of shifts δ ∈ {−2.0,−1.5,−1.0,−0.5,
0.0, 0.5, 1.0, 1.5, 2.0} can be interpreted as shifts on the scale of standard deviation (sd). We present results based
on our TML estimator; results for the one-step estimator were similar. In order to summarize the manner in which
the mean counterfactual risk of HIV-1 infection varies with shifts in the polyfunctionality scores, we consider pro-
jection onto a linear working MSM, as discussed in section 3.4. Our augmented TML estimator ψ?n,δ for the mean
counterfactual risk of HIV-1 infection requires the construction of initial estimators of all nuisance functions.
We used flexible estimation strategies for each of the nuisance parameters. The conditional probability of inclusion
in the second-phase sample was estimated using HAL, adjusting for age, sex, race/ethnicity, body mass index, and a
behavioral risk score for HIV-1 infection. The density qn,A of the CD4+ or CD8+ polyfunctionality scores, conditional
on the same set of covariates, was estimated using our proposed HAL-based density estimator (Hejazi et al., 2020).
The outcome regressionQ0,Y was estimated using super learner (van der Laan et al., 2007), which was used to build an
ensemble model as a weighted combination of prediction functions from a diverse collection of candidate algorithms.
Further details, including choices of learning algorithms and weights assigned to each by the super learner ensemble,
are given in section S4 of the Supplementary Materials. The pseudo-outcome regression, Gn, was fit via HAL.
We note that our choice of estimation strategy — specifically, the use of HAL regression for g0,C and HAL-based
conditional density estimation for q0,A — ensures a sufficiently fast rate of convergence of these nuisance parameter
estimates to their true values under only mild assumptions. Importantly, this allows for the second case described in
lemma 1 to be fulfilled, ensuring consistency of the resultant TML estimates. This consistency of the estimates would
hold even in the case that the HAL regression and super learner ensembles used for G0 and Q0,Y , respectively, proved
inconsistent; however, as both of these nuisance parameters are also estimated via flexible modeling approaches, it
would be expected that the conditions of theorem 1 are made to hold. Thus, we expect that our TML estimates of
the counterfactual risk of HIV-1 infection across the grid in δ will be consistent and (quite possibly) nonparametric-
efficient. Taking advantage of the robustness built into our estimation strategy lends an additional degree of reliability
as to the results of our analysis of the HVTN 505 data. Finally, we recall that the estimate of β0, the slope of
the marginal structural model through the TML estimates of the counterfactual risk in δ, is endowed with the same
consistency and efficiency properties as the individual TML estimates.
Results of applying our estimation procedure separately to both the CD4+ and CD8+ polyfunctionality scores are
presented in Figure 3.
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Figure 3: TML estimates of the counterfactual mean of HIV-1 infection under stochastic interventions on CD4+ (top)
and CD8+ (bottom) standardized polyfunctionality scores. Inference for the estimates is based on pointwise Wald-type
confidence intervals. The slope of a linear working MSM βˆTMLE summarizes the effect of shifting the polyfunctionality
scores on the mean counterfactual risk of HIV-1 infection.
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Examination of the point estimates and confidence intervals of ψ0,δ in Figure 3 reveals that downshifts in the CD4+
polyfunctionality score led to a small increase in estimated HIV-1 infection risk (Figure 3, top panel). For example, a
shift of two standard units lower in the CD4+ polyfunctionality score was found to double the risk of HIV-1 infection.
The estimated slope parameter of the working MSM βˆTMLE pointed to an estimated decrease in risk of about -0.3%
per standard unit of CD4+ polyfunctionality change.
The estimated result of shifts in the polyfunctionality score of the CD8+ immunogenic marker displayed a markedly
much stronger relationship with the risk of HIV-1 infection (Figure 3, lower panel). While positive shifts of the
standardized CD8+ polyfunctionality score beyond those observed in the trial do not appear to have a strong effect on
HIV-1 infection risk, shifts that lower the CD8+ polyfunctionality score display a negative linear trend, indicating that
decreases in CD8+ marker activity adversely affect the risk of HIV-1 infection. At the largest negative shift considered,
the counterfactual HIV-1 infection risk is over four times that observed in the HVTN 505 trial.
Overall, the results of our analyses support the conclusions of Janes et al. (2017) and Fong et al. (2018), further
indicating that modulation of the CD4+ and CD8+ polyfunctionality scores may reduce the risk of HIV-1 infection,
with CD8+ polyfunctionality playing a particularly important role. Notably, our analysis differs from the previous
efforts in two ways: our estimates (i) are based on a formal causal model, which provides an alternative estimand
to summarize relationships between immunogenic response and risk of HIV-1 infection, and (ii) leverage machine
learning to allow the use of flexible modeling strategies while simultaneously delivering robust inference.
6 Discussion
Our analysis of the HVTN 505 trial could be improved in several respects. First, there was participant dropout observed
in the trial, which our analysis ignored. A more robust analysis could leverage available covariate information to
account for potentially informative missingness. Beyond this issue, there are several other directions for potentially
interesting extensions. It would be of interest to extend our estimation strategy to other effects based on stochastic
interventions, including the population intervention (in)direct effects (Dı´az and Hejazi, 2020) defined in mediation
analysis and the incremental propensity score interventions of Kennedy (2019). Extending our estimation strategy to
such settings and its application in analyzing other vaccine efficacy trials will be the subject of future research.
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S1 Conditional Density Estimation Based on the Highly Adaptive Lasso
In section 3.1, several of the challenges associated with conditional density estimation were briefly expressed. The
auxiliary covariate given in equation (3) of the EIF is a ratio of such conditional densities. In the construction of our
proposed estimators, the exposure mechanism q0,A is a density of the intervention A, conditional on the observed
covariates W , which must be evaluated at both the observed values and the post-intervention counterfactual values.
As consistent estimation of the the generalized propensity score is an integral part of our proposed methodology, we
outline here a conditional density estimator, built around the HAL regression function, that achieves the convergence
rate required by our formal theorem. We note that proposals for the data adaptive estimation of such quantities are
sparse in the literature (e.g., Zhu et al., 2015). Notably, Dı´az and van der Laan (2011) gave a proposal for constructing
semiparametric estimators of such a target quantity based on exploiting the relationship between the hazard and density
functions. Our proposal builds upon theirs in several key ways: (i) we adjust their algorithm so as to incorporate
sample-level weights, necessary for making use of inverse probability of censoring weights; and (ii) we replace their
use of an arbitrary classification model with one based on the HAL regression function. While our first modification
is general and may be applied to the estimation strategy Dı´az and van der Laan (2011) propose, our latter contribution
requires adjusting the penalization aspect of HAL regression to respect the use of a loss function appropriate for
prediction on the hazard scale. To make these contributions widely accessible, we introduce the haldensify R
package (Hejazi et al., 2020), available at https://github.com/nhejazi/haldensify
To build an estimator of a conditional density, Dı´az and van der Laan (2011) considered discretizing the observed
a ∈ A based on a number of bins T and a binning procedure (e.g., including the same number of points in each bin
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or forcing bins to be of the same length). We note that the choice of the tuning parameter T corresponds roughly to
the choice of bandwidth in classical kernel density estimation; this will be made clear upon further examination of
the proposed algorithm. The data {A,W} are reformatted such that the hazard of an observed value a ∈ A falling
in a given bin may be evaluated via standard classification techniques. In fact, this proposal may be viewed as a
re-formulation of the classification problem into a corresponding set of hazard regressions:
P(a ∈ [αt−1, αt) |W ) =P(a ∈ [αt−1, αt) | A ≥ αt−1,W )×
t−1∏
j=1
{1− P(a ∈ [αj−1, αj) | A ≥ αj−1,W )},
where the probability that a value of a ∈ A falls in a bin [αt−1, αt) may be directly estimated from a standard
classification model. The likelihood of this model may be re-expressed in terms of the likelihood of a binary variable
in a data set expressed through a repeated measures structure. Specifically, this re-formatting procedure is carried out
by creating a data set in which any given observationAi appears (repeatedly) for as many intervals [αt−1, αt) that there
are prior to the interval to which the observed a belongs. A new binary outcome variable, indicating Ai ∈ [αt−1, αt),
is recorded as part of this new data structure. With the re-formatted data, a pooled hazard regression, spanning the
support of A is then executed. Finally, the conditional density estimator
qn,α(a |W ) = P(a ∈ [αt−1, αt) |W )
(αt − αt−1) ,
for αt−1 ≤ a < αt, may be constructed. As part of this procedure, the hazard estimates are mapped to density
estimates through rescaling of the estimates by the bin size (αt − αt−1).
In its original proposal, a key element of this procedure was the use of any arbitrary classification procedure for
estimating P(a ∈ [αt−1, αt) | W ), facilitating the incorporation of flexible, data adaptive estimators. We alter this
proposal in two ways, (i) replacing the arbitrary estimator of P(a ∈ [αt−1, αt) | W ) with HAL regression and (ii)
accommodating the use of sample-level weights, making it possible for the resultant conditional density estimator to
achieve a convergence rate with respect to a loss-based dissimilarity of n−1/4 under only mild assumptions. This is
an important advance that is needed for the asymptotic analysis of our proposed estimators, as per section 3.2.3. As a
secondary advance, our procedure alters the HAL regression function to use a loss function tailored for estimation of
the hazard, invoking `1-penalization in a manner consistent with this loss.
S2 Proof of Theorem 1
We now examine a proof of the theorem establishing conditions for the weak convergence of our efficient estimators.
Building upon section 2, note that the full data parameter may be expressed as a mapping ΨF : MX → R and that
ΨF (PX0 ) ≡ ΨF (Q0,Y ), since the parameter mapping depends on PX0 only through the functional Q0,Y . We recall
that the EIF DF (Q0,Y , g0,A) coincides with the canonical gradient of the parameter mapping Ψ
F :MX → R, since
a regular asymptotically linear estimator with influence function equal to the canonical gradient is asymptotically
efficient (Bickel et al., 1993; van der Laan and Robins, 2003). Note further that the observed data parameter is defined
such that Ψ(P0) ≡ ΨF (PX0 ), where the observed data parameter mapping Ψ :M→ R is pathwise differentiable at a
distribution P in the statistical model with a gradient given by the EIF:
D(G0, g0,C , D
F (Q0,Y , q0,A))(o) =
C
g0,C(y, w)
DF (Q0,Y , q0,A)(x)−
G0(y, w)
g0,C(y, w)
(C − g0,C(y, w)) .
The class of all gradients of Ψ at P is given by {D(G0, g0,C , DF (PX)) : DF (PX)} where DF (PX) varies over
all gradients of the full data parameter ΨF at distributions PX ∈ MX . As DF varies, G0 also necessarily varies
since it is defined as the conditional mean of DF given {C = 1, Y,W}. In particular, if the full data modelMX is
nonparametric, then there is only one full data gradient, which is the canonical gradient (or EIF) of Ψ at P .
In the sequel, let ‖f‖2 = E{f(O)2}1/2 denote the L2(P0) norm of a P0-measurable function f , define G˜0 :=
EP0 [DF (Q
?
n,Y , qn,A)(O) | C = 1, Y,W ], and let Gn be the estimate of G˜0. An exact characterization of the second-
order remainder for the full data parameter ΨF (PX)−ΨF (PX0 ) is given by
RF2 (Qn,Y , qn,A, Q0,Y , q0,A) := Ψ
F (Qn,Y )−ΨF (Q0,Y ) + EPX0 [D
F (Qn,Y , qn,A)]
while the exact second-order remainder for the observed data parameter Ψ(P )−Ψ(P0) is analogously defined
R2(P, P0) := Ψ(P )−Ψ(P0) + EP0 [D(Gn, gn,C , DF (Qn,Y , qn,A))].
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Combining these definitions, the exact second-order remainder for the observed data parameter may be expressed in
terms of the second-order remainder of its full data counterpart:
R2(P, P0) = R
F
2 (Qn,Y , qn,A, Q0,Y , q0,A) + EP0
[(
gn,C − g0,C
gn,C
)
(Gn − G˜0)
]
.
Assume the following conditions:
C1. EPnD(Gn, g?n,C , DF (Q
?
n,Y , qn,A)) = 0.
C2. g0,C > ζ > 0 and g?n,C > ζ with probability tending to 1 for some ζ > 0.
C3. ‖Gn − G˜0‖P0 = oP (n−1/4) and ‖g?n,C − g0,C‖P0 = oP (n−1/4).
C4. RF2 (Q
?
n,Y , qn,A, Q0,Y , q0,A) = oP (n
−1/2).
C5. ‖D(Gn, g?n,C , DF (Q
?
n,Y , qn,A))−D(G0, g0,C , DF (Q0,Y , q0,A))‖P0 = oP (1).
C6. Let F?v (M) be the class of cadlag functions f on a cube [0, τ ] ⊂ Rd (for some integer d), for which the sectional
variation norm ‖f‖?v is bounded by a universal constant M < ∞. Assume that D(Gn, g?n,C , DF (Q
?
n,Y , qn,A)) ∈
F?v (M) with probability tending to 1 (n.b., the definition F?v (M) can be replaced by any Donsker class).
Proof [Theorem 1: asymptotic linearity and efficiency of the TML estimator ψ?n,δ] Under conditions C1–C6, we have
EPnD(Gn, g?n,C , DF (Q
?
n,Y , qn,A)) = oP (n
−1/2); moreover, by definition of R2(P, P0):
ΨF (Q
?
n,Y )−ΨF (Q0,Y ) =− EP0 [D(Gn, g?n,C , DF (Q
?
n,Y , qn,A))]
+RF2 (Q
?
n,Y , qn,A, Q0,Y , q0,A) + EP0
[(
g?n,C − g0,C
g?n,C
)
(Gn − G˜0)
]
.
Combining with condition C1, we have
ΨF (Q
?
n,Y )−ΨF (Q0,Y ) =EPn [D(Gn, g?n,C , DF (Q
?
n,Y , qn,A))]− EP0 [D(Gn, g?n,C , DF (Q
?
n,Y , qn,A))]
+RF2 (Q
?
n,Y , qn,A, Q0,Y , q0,A) + EP0
[(
g?n,C − g0,C
g?n,C
)
(Gn − G˜0)
]
Conditions C5 and C6 imply that the sum of the first two terms equals EPn [D(G0, g?0,C , DF (Q
?
0,Y , q0,A)(O)] +
oP (n
−1/2). Condition C4 ensures the third term equals oP (n−1/2). Conditions C2 and C3 imply that the fourth term
equals oP (n−1/2), which completes the proof. An analogous proof holds for the one-step estimator ψ+n,δ when the
initial estimates Qn,Y and gn,C are used instead of their revised counterparts. Here, we do not require condition C1,
as our proposed estimation procedure guarantees that it will be attained.
S3 Results of Additional Simulation Studies
S3.1 Simulation #1: Comparison of estimator variants under the shifts δ = −0.5 and δ = 0
In the results reported in section 4.1, for our first simulation study under the shift δ = 0.5, we noted excellent
performance of our proposed estimator variants under several standard metrics, including
√
n-bias, n-MSE, and the
coverage of confidence intervals. To further assess the quality of performance of our augmented estimators, we
examine the same six estimator variants under the shifts δ ∈ {−0.5, 0}. Details of the simulation study have been
previously described in section 4.1. As before, results are reported based on aggregation across 1000 repetitions. The
results of these numerical investigations are reported in Figures S1 and S2.
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Figure S1: Results of numerical simulations comparing six estimation strategies for ψ0,δ for δ = 0.
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Figure S2: Results of numerical simulations comparing six estimation strategies for ψ0,δ for δ = −0.5.
Both the reweighted estimators of Rose and van der Laan (2011) and our augmented estimators display the expected
level of performance when the sampling mechanism is estimated via a correctly specified parametric model, standing
out against the performance of their unadjusted counterparts. As in the case of δ = 0.5, the reweighted estimators dis-
play coverage exceeding the desired 95% level, while their augmented analogs cover at exactly the nominal level. This
suggests again that the reweighted estimators exhibit an inflated variance relative to that of our augmented estimators.
The lower panel of each figure visualizes differences in the performance of the estimators when the sampling mecha-
nism is estimated flexibly via HAL. These results reveal a significant discrepancy in the performance of the reweighted
and augmented estimators, with our augmented one-step and TML estimators outperforming their reweighted coun-
terparts in terms of
√
n-bias, n-MSE, and coverage. In this second case, we note that the TML estimators appear
to exhibit a small degree of estimation instability at n = 100, displaying larger n-MSE in both the reweighted and
augmented variants. We conjecture that this performance is due to an instability induced by the targeting procedure
— in practice, this could be ameliorated by alterations to the convergence criterion. Overall, the results of these nu-
merical investigations do not differ substantially from those presented in section 4.1, establishing that our augmented
estimators improve upon alternative estimation strategies when nonparametric estimation of g0,C is performed.
S3.2 Simulation #2: Comparing estimators in a scenario inspired by HVTN 505, without effect of treatment
To further assess the performance of our augmented estimators in a scenario like the HVTN 505 trial, we replace the
structural equation for the outcome Y with a draw from the Bernoulli distribution parameterized as Bernoulli(p =
expit(−2.8 − 0.0013W1 − 0.0016W2 + 0.0678W3 + 0.039W4)) to achieve a setting in which there is no effect of
the treatment on the outcome. In this case, the outcome process is relatively rare, with P(Y = 1 | A,W ) ≈ 0.053.
The structural equations for other components of the observed data O are unaltered. In this setting, the true parameter
value was approximated to be ψ0,δ = 0.0526 regardless of the value of δ. We present the results of assessing our
augmented estimators in Figure S3.
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Figure S3: Results of numerical simulations comparing our two proposed estimators of ψ0,δ for a grid of δ, across
1000 Monte Carlo simulations at n = 1400.
As the ground truth of the effect of shifting the post-vaccination activity of the CD4+ and CD8+ immunogenic markers
on the risk of HIV-1 infection is unknown in the HVTN 505 trial, we assess our estimators in this scenario so as to be
sure of there performance when no effect of treatment is present. Estimation of all nuisance parameters is performed
using exactly the same techniques outlined previously in section 4.2.
In terms of bias and MSE, our proposed estimators display adequate performance: the augmented one-step and TML
estimators are effectively indistinguishable in terms of MSE, while, in terms of bias, the augmented TML estimator
appears to outperform the one-step estimator uniformly across all values of δ, likely on account of the enhanced
finite-sample performance of TML estimators (van der Laan and Rose, 2011). As with the numerical investigations
presented in section 4.2, these results suggest that our augmented estimators will perform well enough to allow accurate
estimation of ψ0,δ when applied to data from the HVTN 505 trial.
S4 Super Learner Ensemble Models for Qn,Y in the HVTN 505 Data Analysis
As noted in section 5, for both the CD4+ and CD8+ analyses, the estimated outcome mechanismQn,Y was constructed
from an ensemble model based on the super learner algorithm (van der Laan et al., 2007). The cross-validation selector
that forms the basis of the super learner has been shown to exhibit unique theoretical guarantees, including asymptotic
equivalence to the oracle selector (van der Laan et al., 2004, 2006; van der Vaart et al., 2006), that make its use
preferable over other ensemble learning approaches.
A rich library of candidate classification algorithms was considered in the super learner ensemble model for Qn,Y .
These included `1-penalized lasso regression (Tibshirani, 1996; Friedman et al., 2009); `2-penalized ridge regression
(Tikhonov and Arsenin, 1977; Hoerl and Kennard, 1970; Friedman et al., 2009); three elastic net regressions weighting
the `1 penalty at α ∈ {0.25, 0.50, 0.75} and the `2 penaly at (1−α) (Zou and Hastie, 2003; Friedman et al., 2009); ran-
dom forests (Breiman, 2001) with 50, 100, and 500 trees based on its implementation in the ranger R package (Wright
et al., 2017); extreme gradient boosted trees with 20, 50, 100, and 300 fitting iterations (Chen and Guestrin, 2016);
multivariate adaptive polynomial spline regression (Kooperberg et al., 1997; Stone et al., 1994); multivariate adaptive
regression splines (Friedman et al., 1991); generalized linear models with Bayesian priors on parameters; a multilayer
perceptron (Rosenblatt, 1961); and the highly adaptive lasso (van der Laan, 2017; Benkeser and van der Laan, 2016;
Coyle et al., 2019). The implementation of the super learner algorithm in the sl3 R package (Coyle et al., 2020) was
used, and weights assigned to each learning algorithm by the super learner are given in Tables 1 and 2 for the CD4+
and CD8+ analyses, respectively.
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Table 1: Weights and risk estimates assigned to each individual learning algorithm in the ensemble model for Qn,Y
used in the reported re-analysis of the CD4+ immunogenic marker.
Learner Weight Min. Fold Risk Mean CV-Risk Max. Fold Risk
Ridge (`2 penalized) 0.147 0.015 0.036 0.052
Lasso (`1 penalized) 0.000 0.015 0.036 0.052
Elastic net (α = 0.25) 0.116 0.015 0.036 0.051
Elastic net (α = 0.50) 0.000 0.015 0.036 0.051
Elastic net (α = 0.75) 0.181 0.015 0.036 0.051
Random forest (50 trees) 0.000 0.062 0.097 0.173
Random forest (100 trees) 0.000 0.050 0.093 0.153
Random forest (500 trees) 0.000 0.061 0.093 0.158
xgboost(20 iterations) 0.000 0.012 0.072 0.165
xgboost(50 iterations) 0.000 0.012 0.080 0.181
xgboost(100 iterations) 0.010 0.013 0.088 0.192
xgboost(500 iterations) 0.000 0.012 0.098 0.204
Highly adaptive lasso (default) 0.014 0.064 0.074 0.084
Highly adaptive lasso (custom) 0.000 0.066 0.075 0.084
Multivariate adaptive regression splines 0.000 0.050 0.086 0.131
Polynomial spline regression 0.208 0.015 0.036 0.053
Multilayer perceptron network 0.000 0.015 0.037 0.055
GLM with Bayesian priors 0.323 0.015 0.036 0.051
Super Learner 1.000 — — —
In the super learner ensemble model for the outcome regression in the CD4+ analysis, the three best learning algorithms
were a GLM with Bayesian priors on parameter estimates, a polynomial spline regression model, and an elastic
net regression model that favored the `1 (lasso) penalty over the `2 (ridge) penalty. Another variant of elastic net
regression, which favored the `2 penalty over the `1 penalty, and ridge regression were also given nontrivial weights
in the ensemble model. A variant of extreme gradient boosting and the highly adaptive lasso received low weights,
while all other candidate algorithms in the library were assigned weights of zero.
Table 2: Weights and risk estimates assigned to each individual learning algorithm in the ensemble model for Qn,Y
used in the reported re-analysis of the CD8+ immunogenic marker.
Learner Weight Min. Fold Risk Mean CV-Risk Max. Fold Risk
Ridge (`2 penalized) 0.161 0.013 0.037 0.075
Lasso (`1 penalized) 0.161 0.011 0.037 0.075
Elastic net (α = 0.25) 0.003 0.012 0.037 0.075
Elastic net (α = 0.50) 0.000 0.014 0.037 0.076
Elastic net (α = 0.75) 0.131 0.014 0.037 0.074
Random forest (50 trees) 0.090 0.053 0.088 0.129
Random forest (100 trees) 0.055 0.048 0.089 0.136
Random forest (500 trees) 0.119 0.049 0.088 0.127
xgboost(20 iterations) 0.000 0.043 0.064 0.112
xgboost(50 iterations) 0.000 0.036 0.074 0.128
xgboost (100 iterations 0.000 0.031 0.076 0.134
xgboost (300 iterations) 0.000 0.029 0.086 0.146
Highly adaptive lasso (default) 0.000 0.046 0.078 0.115
Highly adaptive lasso (custom) 0.000 0.044 0.078 0.132
Multivariate adaptive regression splines 0.000 0.029 0.100 0.159
Polynomial spline regression 0.000 0.015 0.040 0.080
Multilayer perceptron network 0.067 0.007 0.040 0.085
GLM with Bayesian priors 0.214 0.016 0.037 0.073
Super Learner 1.000 — — —
In the CD8+ analysis, the three best learning algorithms, chosen by the super learner ensemble model for the outcome
regression, were a GLM with Bayesian priors on parameter estimates, ridge regression, and lasso regression. Other
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algorithms that were assigned nontrivial weights included an elastic net regression model that favored the `1 (lasso)
penalty over the `2 (ridge) penalty and a random forest with 500 trees. A variant of elastic net regression, random
forests with 50 and 100 trees, and a multilayer perceptron all received low weights, while all other candidate algorithms
in the library were assigned weights of zero.
References
Benkeser, D. and van der Laan, M. J. (2016). The highly adaptive lasso estimator. In Data Science and Advanced
Analytics (DSAA), 2016 IEEE International Conference on, pages 689–696. IEEE.
Bickel, P. J., Klaassen, C. A., Ritov, Y., and Wellner, J. A. (1993). Efficient and adaptive estimation for semiparametric
models. Johns Hopkins University Press Baltimore.
Breiman, L. (2001). Random forests. Machine learning 45, 5–32.
Chen, T. and Guestrin, C. (2016). xgboost: A scalable tree boosting system. In Proceedings of the 22nd ACM SIGKDD
international conference on knowledge discovery and data mining, pages 785–794. ACM.
Coyle, J. R., Hejazi, N. S., Malenica, I., and Sofrygin, O. (2020). sl3: Modern Pipelines for Machine Learning and
Super Learning. R package version 1.3.7.
Coyle, J. R., Hejazi, N. S., and van der Laan, M. J. (2019). hal9001: The scalable highly adaptive lasso. R package
version 0.2.5.
Dı´az, I. and van der Laan, M. J. (2011). Super learner based conditional density estimation with application to marginal
structural models. The international journal of biostatistics 7, 1–20.
Friedman, J., Hastie, T., and Tibshirani, R. (2009). glmnet: Lasso and elastic-net regularized generalized linear models.
R package version 1,.
Friedman, J. H. et al. (1991). Multivariate adaptive regression splines. The annals of statistics 19, 1–67.
Hejazi, N. S., Benkeser, D. C., and van der Laan, M. J. (2020). haldensify: Conditional density estimation with the
highly adaptive lasso. R package version 0.0.5.
Hoerl, A. E. and Kennard, R. W. (1970). Ridge regression: Biased estimation for nonorthogonal problems. Techno-
metrics 12, 55–67.
Kooperberg, C., Bose, S., and Stone, C. J. (1997). Polychotomous regression. Journal of the American Statistical
Association 92, 117–127.
Rose, S. and van der Laan, M. J. (2011). A targeted maximum likelihood estimator for two-stage designs. The
international journal of biostatistics 7, 1–21.
Rosenblatt, F. (1961). Principles of neurodynamics. perceptrons and the theory of brain mechanisms.
Stone, C. J. et al. (1994). The use of polynomial splines and their tensor products in multivariate function estimation.
The Annals of Statistics 22, 118–171.
Tibshirani, R. (1996). Regression shrinkage and selection via the lasso. Journal of the Royal Statistical Society: Series
B (Statistical Methodology) 58, 267–288.
Tikhonov, A. N. and Arsenin, V. I. (1977). Solutions of ill-posed problems, volume 14. Winston, Washington, DC.
van der Laan, M. J. (2017). A generally efficient targeted minimum loss based estimator based on the highly adaptive
lasso. The International Journal of Biostatistics 13,.
van der Laan, M. J., Dudoit, S., and Keles, S. (2004). Asymptotic optimality of likelihood-based cross-validation.
Statistical Applications in Genetics and Molecular Biology 3, 1–23.
van der Laan, M. J., Dudoit, S., and van der Vaart, A. W. (2006). The cross-validated adaptive epsilon-net estimator.
Statistics & Decisions 24, 373–395.
van der Laan, M. J., Polley, E. C., and Hubbard, A. E. (2007). Super Learner. Statistical Applications in Genetics and
Molecular Biology 6,.
van der Laan, M. J. and Robins, J. M. (2003). Unified Methods for Censored Longitudinal Data and Causality.
Springer Series in Statistics. Springer New York.
van der Laan, M. J. and Rose, S. (2011). Targeted Learning: Causal Inference for Observational and Experimental
Data. Springer Science & Business Media.
van der Vaart, A. W., Dudoit, S., and van der Laan, M. J. (2006). Oracle inequalities for multi-fold cross validation.
Statistics & Decisions 24, 351–371.
8
APRIL 7, 2020
Wright, M. N., Ziegler, A., et al. (2017). ranger: A fast implementation of random forests for high dimensional data
in C++ and R. Journal of Statistical Software 77,.
Zhu, Y., Coffman, D. L., and Ghosh, D. (2015). A boosting algorithm for estimating generalized propensity scores
with continuous treatments. Journal of causal inference 3, 25–40.
Zou, H. and Hastie, T. (2003). Regression shrinkage and selection via the elastic net, with applications to microarrays.
Journal of the Royal Statistical Society: Series B (Statistical Methodology) 67, 301–20.
9
